Dually fibronectin/CD44-mediated nanoparticles targeted disrupt the Golgi apparatus and inhibit the hedgehog signaling in activated hepatic stellate cells to alleviate liver fibrosis.
Biomaterials
; 301: 122232, 2023 10.
Article
in En
| MEDLINE
| ID: mdl-37418856
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Nanoparticles
/
Hepatic Stellate Cells
Limits:
Animals
Language:
En
Journal:
Biomaterials
Year:
2023
Document type:
Article